Filter by:
Finding the genes that increase the risk of developing T1D
Dr Ying Wong is using cutting-edge genetics technology to identify the most promising genetic targets for future prevention therapies.
Advancing early detection: evaluating the effectiveness of nation-wide T1D screening
Dr Kirstine Bell is leading the world’s first clinical trial of type 1 diabetes (T1D) screening to assess its effectiveness and feasibility when implemented in the Australian healthcare system.
Advancing early detection: preparing Australia for nation-wide T1D screening
Professor John Wentworth is expanding Australia’s type 1 diabetes (T1D) screening initiative, increasing its testing capacity and streamlining clinical pathways.
Advancing early detection: implementing the best care for people with early-stage T1D
In preparation for population-wide screening for T1D, Professor Jennifer Couper is evaluating which modes of care are best suited for those in the early stages of type 1 diabetes (T1D).
Preventing type 1 diabetes by exhausting the immune system
Professor Tom Kay is learning more about how we can target just the immune cells that go awry in type 1 diabetes (T1D) to delay or even prevent T1D progression.
Developing a novel oral insulin to treat type 1 diabetes (T1D)
The aim of Dr Rong Xu’s Breakthrough T1D-funded project is to develop a new type of insulin that can be taken orally and detect and respond to rising blood glucose levels itself.
Understanding how genetic risk drives development of T1D
Professor Simon Barry is trying to understand how genetic risk factors change the behaviour of immune cells over time in people who develop type 1 diabetes (T1D).
Protecting transplanted beta cells from rejection
Dr Seigmund Lai’s Breakthrough T1D-funded project is looking for ways to replace the insulin-making cells lost in type 1 diabetes (T1D) without the need for long-term use of immunosuppressant drugs.
Can tirzepatide help stabilise blood glucose in people with T1D?
A weekly injection of tirzepatide could help people with type 1 diabetes (T1D) keep their blood glucose in a healthy range.
Using CGMs to unlock the potential of disease-modifying therapies
Continuous glucose monitors (CGMs) could pinpoint when therapies to delay the progression of early-stage type 1 diabetes (T1D) could be beneficial.
Understanding children in T1D screening programs
How children and their caregivers' experiences of type 1 diabetes (T1D) screening and monitoring programs can help us support young people diagnosed in the early stages of the condition.
Can a simple urine test reveal the stage of T1D a child is in?
A protein called C-peptide could be useful for monitoring the development progression of type 1 diabetes in children in the earliest stages of the condition.
Can sotagliflozin help stabilise blood glucose levels?
The clinical trial is testing whether sotagliflozin could improve blood glucose levels in people with type 1 diabetes (T1D), while mitigating potential risks of dangerous side effects.
